Published in Mol Membr Biol on February 04, 1998
Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol (2008) 5.26
Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol (2001) 3.58
Close is not enough: SNARE-dependent membrane fusion requires an active mechanism that transduces force to membrane anchors. J Cell Biol (2000) 2.91
The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement. J Membr Biol (2004) 2.59
A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol Biol Cell (1999) 2.34
Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion. Mol Biol Cell (1999) 2.10
Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm. Retrovirology (2008) 1.89
Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins. J Virol (2006) 1.71
Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses (2012) 1.55
A host-guest system to study structure-function relationships of membrane fusion peptides. Proc Natl Acad Sci U S A (2000) 1.47
Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion. Biophys J (2000) 1.40
Membrane fusion mediated by coiled coils: a hypothesis. Biophys J (2000) 1.38
Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein. J Virol (2000) 1.33
The central proline of an internal viral fusion peptide serves two important roles. J Virol (2000) 1.33
Structure and plasticity of the human immunodeficiency virus gp41 fusion domain in lipid micelles and bilayers. Biophys J (2007) 1.30
Varicella-zoster Virus gB and gE coexpression, but not gB or gE alone, leads to abundant fusion and syncytium formation equivalent to those from gH and gL coexpression. J Virol (2001) 1.29
Conformational intermediates and fusion activity of influenza virus hemagglutinin. J Virol (1999) 1.25
A strong correlation between fusogenicity and membrane insertion depth of the HIV fusion peptide. Proc Natl Acad Sci U S A (2009) 1.23
Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. J Virol (2009) 1.18
Ubiquitous activation of the Nipah virus fusion protein does not require a basic amino acid at the cleavage site. J Virol (2004) 1.18
HIV fusion peptide and its cross-linked oligomers: efficient syntheses, significance of the trimer in fusion activity, correlation of beta strand conformation with membrane cholesterol, and proximity to lipid headgroups. Biochemistry (2009) 1.17
Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. J Virol (2005) 1.16
Conformational flexibility and strand arrangements of the membrane-associated HIV fusion peptide trimer probed by solid-state NMR spectroscopy. Biochemistry (2006) 1.13
Properties and structures of the influenza and HIV fusion peptides on lipid membranes: implications for a role in fusion. Biophys J (2005) 1.08
Fv-4: identification of the defect in Env and the mechanism of resistance to ecotropic murine leukemia virus. J Virol (2001) 1.05
Palmitoylation, membrane-proximal basic residues, and transmembrane glycine residues in the reovirus p10 protein are essential for syncytium formation. J Virol (2003) 1.04
Implicit solvent model studies of the interactions of the influenza hemagglutinin fusion peptide with lipid bilayers. Biophys J (2001) 1.04
Oligomeric beta-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers. Biophys J (2004) 1.04
The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface. EMBO J (2001) 1.03
HIV fusion peptide penetrates, disorders, and softens T-cell membrane mimics. J Mol Biol (2010) 1.02
Cell fusion activities of Hantaan virus envelope glycoproteins. J Virol (2004) 1.01
Structural and functional properties of an unusual internal fusion peptide in a nonenveloped virus membrane fusion protein. J Virol (2004) 1.00
A critical evaluation of the conformational requirements of fusogenic peptides in membranes. Eur Biophys J (2006) 0.99
Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide. J Virol (2001) 0.98
Major antiparallel and minor parallel β sheet populations detected in the membrane-associated human immunodeficiency virus fusion peptide. Biochemistry (2010) 0.96
A conserved sequence within the H2 subunit of the vaccinia virus entry/fusion complex is important for interaction with the A28 subunit and infectivity. J Virol (2008) 0.96
Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane. Biochemistry (2008) 0.95
Hairpin folding of HIV gp41 abrogates lipid mixing function at physiologic pH and inhibits lipid mixing by exposed gp41 constructs. Biochemistry (2009) 0.93
Insights into the mechanism of HIV-1 envelope induced membrane fusion as revealed by its inhibitory peptides. Eur Biophys J (2011) 0.93
The presence of a single N-terminal histidine residue enhances the fusogenic properties of a Membranotropic peptide derived from herpes simplex virus type 1 glycoprotein H. J Biol Chem (2010) 0.90
Discrete domains within the rotavirus VP5* direct peripheral membrane association and membrane permeability. J Virol (2004) 0.89
The three lives of viral fusion peptides. Chem Phys Lipids (2014) 0.87
Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion. J Virol (2006) 0.87
Chemical shift assignment and structural plasticity of a HIV fusion peptide derivative in dodecylphosphocholine micelles. Biochim Biophys Acta (2007) 0.87
Solid-state NMR spectroscopy of the HIV gp41 membrane fusion protein supports intermolecular antiparallel β sheet fusion peptide structure in the final six-helix bundle state. J Mol Biol (2013) 0.86
Nuclear magnetic resonance evidence for retention of a lamellar membrane phase with curvature in the presence of large quantities of the HIV fusion peptide. Biochim Biophys Acta (2009) 0.86
Irregular structure of the HIV fusion peptide in membranes demonstrated by solid-state NMR and MD simulations. Eur Biophys J (2011) 0.85
Detection of closed influenza virus hemagglutinin fusion peptide structures in membranes by backbone (13)CO- (15)N rotational-echo double-resonance solid-state NMR. J Biomol NMR (2013) 0.83
Investigation of pathways for the low-pH conformational transition in influenza hemagglutinin. Biophys J (2003) 0.82
A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion. Proc Natl Acad Sci U S A (1998) 0.82
Folded monomers and hexamers of the ectodomain of the HIV gp41 membrane fusion protein: potential roles in fusion and synergy between the fusion peptide, hairpin, and membrane-proximal external region. Biochemistry (2014) 0.81
Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures. J Phys Chem A (2013) 0.81
Analysis of local conformation of membrane-bound and polycrystalline peptides by two-dimensional slow-spinning rotor-synchronized MAS exchange spectroscopy. J Biomol NMR (2003) 0.81
Ultrastructural characterization of peptide-induced membrane fusion and peptide self-assembly in the lipid bilayer. Biophys J (1999) 0.80
Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy. Curr Top Med Chem (2011) 0.80
A GxxxG-like motif within HIV-1 fusion peptide is critical to its immunosuppressant activity, structure, and interaction with the transmembrane domain of the T-cell receptor. J Biol Chem (2012) 0.79
Closed and Semiclosed Interhelical Structures in Membrane vs Closed and Open Structures in Detergent for the Influenza Virus Hemagglutinin Fusion Peptide and Correlation of Hydrophobic Surface Area with Fusion Catalysis. J Am Chem Soc (2015) 0.79
Atypical fusion peptide of Nelson Bay virus fusion-associated small transmembrane protein. J Virol (2005) 0.79
The SCHOOL of nature: IV. Learning from viruses. Self Nonself (2010) 0.77
Stochastic simulation of hemagglutinin-mediated fusion pore formation. Biophys J (2001) 0.77
The SCHOOL of nature: III. From mechanistic understanding to novel therapies. Self Nonself (2010) 0.77
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation (1996) 9.00
Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull (1993) 7.03
Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol (1993) 5.17
Secretion of Yop proteins by Yersiniae. Infect Immun (1990) 4.64
Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis. J Cell Biol (1999) 3.77
Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers (1998) 3.25
Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J Cell Biol (1998) 3.23
Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. J Virol (1990) 3.18
Multiplex PCR for the detection of tetracycline resistant genes. Mol Cell Probes (2001) 3.03
Membrane asymmetry in epithelia: is the tight junction a barrier to diffusion in the plasma membrane? Nature (1981) 3.01
Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J (1999) 2.93
Liposome-cell interaction: transfer and intracellular release of a trapped fluorescent marker. Science (1977) 2.89
Restricted movement of lipid and aqueous dyes through pores formed by influenza hemagglutinin during cell fusion. J Cell Biol (1994) 2.87
Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. Measurement by dequenching of fluorescence. J Biol Chem (1989) 2.82
Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J Biol Chem (1998) 2.57
Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry (1992) 2.50
Initial stages of influenza hemagglutinin-induced cell fusion monitored simultaneously by two fluorescent events: cytoplasmic continuity and lipid mixing. J Cell Biol (1989) 2.40
Lateral diffusion of surface immunoglobulin, Thy-1 antigen, and a lipid probe in lymphocyte plasma membranes. Proc Natl Acad Sci U S A (1979) 2.29
The 21-residue surfactant peptide (LysLeu4)4Lys(KL4) is a transmembrane alpha-helix with a mixed nonpolar/polar surface. FEBS Lett (1996) 2.19
Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films. Eur J Biochem (1990) 2.19
Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J Orthop Res (1999) 2.19
Design of liposomes for enhanced local release of drugs by hyperthermia. Science (1978) 2.17
Attenuated total reflection infrared spectroscopy of proteins and lipids in biological membranes. Biochim Biophys Acta (1999) 2.17
Kinetics of the opening and closing of individual excitability-inducing material channels in a lipid bilayer. J Gen Physiol (1974) 2.15
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci (2005) 2.08
HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process. Biochemistry (2001) 2.07
The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology (1993) 2.05
Genetic characterization of antimicrobial resistance in Canadian isolates of Salmonella serovar Typhimurium DT104. Antimicrob Agents Chemother (1999) 2.03
Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol Prog (1998) 2.03
Interferon-beta is required for interferon-alpha production in mouse fibroblasts. Curr Biol (1998) 1.95
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Determination of soluble and membrane protein structure by Fourier transform infrared spectroscopy. III. Secondary structures. Subcell Biochem (1994) 1.92
Conformational changes and fusion activity of influenza virus hemagglutinin of the H2 and H3 subtypes: effects of acid pretreatment. J Virol (1990) 1.91
Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry (1997) 1.90
Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. J Virol (1999) 1.89
Charge clusters and the orientation of membrane proteins. J Membr Biol (1982) 1.87
Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density. J Virol (1991) 1.87
Voltage-dependent trans-bilayer orientation of melittin. J Biol Chem (1982) 1.86
Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem (2001) 1.86
Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res (2000) 1.83
The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J Biol Chem (2000) 1.79
The World Heart Federation's white book: impending global pandemic of cardiovascular diseases: challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition. Can J Cardiol (2000) 1.77
Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry (1995) 1.77
pH-dependent lysis of liposomes by adenovirus. Biochemistry (1986) 1.74
Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnol Bioeng (2003) 1.69
Yersinia enterocolitica type III secretion-translocation system: channel formation by secreted Yops. EMBO J (1999) 1.68
Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. J Virol (2000) 1.67
Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother (2000) 1.66
Electrical detection of the spin resonance of a single electron in a silicon field-effect transistor. Nature (2004) 1.64
Membrane molecule reorientation in an electric field recorded by attenuated total reflection Fourier-transform infrared spectroscopy. Biophys J (2001) 1.63
Determination of soluble and membrane protein structure by Fourier transform infrared spectroscopy. I. Assignments and model compounds. Subcell Biochem (1994) 1.63
Gating kinetics of pH-activated membrane fusion of vesicular stomatitis virus with cells: stopped-flow measurements by dequenching of octadecylrhodamine fluorescence. Biochemistry (1990) 1.63
[A theory of electric excitation of biological membranes]. C R Acad Sci Hebd Seances Acad Sci D (1970) 1.63
AIDS vaccine development. Science (1998) 1.62
Molecular typing of Neisseria gonorrhoeae causing repeated infections: evolution of porin during passage within a community. J Infect Dis (1999) 1.62
Rapid entry of bitter and sweet tastants into liposomes and taste cells: implications for signal transduction. Am J Physiol Cell Physiol (2000) 1.59
Observation of single influenza virus-cell fusion and measurement by fluorescence video microscopy. Proc Natl Acad Sci U S A (1990) 1.58
Characterization of the levanase gene of Bacillus subtilis which shows homology to yeast invertase. Mol Gen Genet (1987) 1.58
Tissue engineering of cartilage in space. Proc Natl Acad Sci U S A (1997) 1.57
The use of fluorescence dequenching measurements to follow viral membrane fusion events. Methods Biochem Anal (1988) 1.56
Micelle-vesicle transition of egg phosphatidylcholine and octyl glucoside. Biochemistry (1988) 1.54
Membrane helix orientation from linear dichroism of infrared attenuated total reflection spectra. Biophys J (1999) 1.52
Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut (1995) 1.52
Diffusion and patching of macromolecules on planar lipid bilayer membranes. Biochemistry (1977) 1.51
Saposin fold revealed by the NMR structure of NK-lysin. Nat Struct Biol (1997) 1.49
Liposomes as targets for granule cytolysin from cytotoxic large granular lymphocyte tumors. Proc Natl Acad Sci U S A (1984) 1.49
Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides. Biopolymers (1995) 1.48
On the structure and operation of type I DNA restriction enzymes. J Mol Biol (1999) 1.48
The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). J Biol Chem (1994) 1.46
Activation of vesicular stomatitis virus fusion with cells by pretreatment at low pH. J Biol Chem (1988) 1.45
The molecular composition of some lipid bilayer membranes in aqueous solution. J Membr Biol (1972) 1.44
Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein. J Virol (1992) 1.44
Integration of engineered cartilage. J Orthop Res (2001) 1.44
pH-dependent fusion induced by vesicular stomatitis virus glycoprotein reconstituted into phospholipid vesicles. J Biol Chem (1984) 1.44
Role of the carboxy terminus of Escherichia coli FtsA in self-interaction and cell division. J Bacteriol (2000) 1.43
The structure and organization within the membrane of the helices composing the pore-forming domain of Bacillus thuringiensis delta-endotoxin are consistent with an "umbrella-like" structure of the pore. Proc Natl Acad Sci U S A (1998) 1.43
Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation. J Mol Biol (2000) 1.42
Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes. J Mol Biol (1996) 1.42
Chondrogenesis in a cell-polymer-bioreactor system. Exp Cell Res (1998) 1.42
Structure and topology of the influenza virus fusion peptide in lipid bilayers. J Biol Chem (1995) 1.41
Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion. J Biol Chem (1993) 1.40
Identification of the paired basic convertases implicated in HIV gp160 processing based on in vitro assays and expression in CD4(+) cell lines. J Biol Chem (1996) 1.40
Interaction of tubulin with phospholipid vesicles. I. Association with vesicles at the phase transition. J Biol Chem (1981) 1.40
Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage. J Biol Chem (2001) 1.39
Time for the specialty to unite, reform and inform. Br J Oral Maxillofac Surg (1994) 1.39
An unusual cause of postmenopausal bleeding and incontinence of urine: primary lymphoma of the vagina. Br J Obstet Gynaecol (1995) 1.39
Mode of action of the antibacterial cecropin B2: a spectrofluorometric study. Biochemistry (1994) 1.37
Structural characterization of the hydrophobin SC3, as a monomer and after self-assembly at hydrophobic/hydrophilic interfaces. Biophys J (1998) 1.35
Why Bacillus thuringiensis insecticidal toxins are so effective: unique features of their mode of action. FEMS Microbiol Lett (2001) 1.35
Kinetics of HIV-1 interactions with sCD4 and CD4+ cells: implications for inhibition of virus infection and initial steps of virus entry into cells. Virology (1992) 1.34
Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes. AIDS Res Hum Retroviruses (1991) 1.32
Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J Virol (1996) 1.32
Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. J Biol Chem (1991) 1.30
Secondary structure and orientation of the surfactant protein SP-B in a lipid environment. A Fourier transform infrared spectroscopy study. Biochemistry (1992) 1.28
What do culturally sensitive mental health services mean? The case of Hispanics. Am Psychol (1987) 1.28